Imfinzi genuine price

Durvalumab is used to treat various cancers such as non-small cell lung cancer and small cell lung cancer by blocking the immune escape mechanism of tumor cells. Durvalumab is an intravenous injection and must be used under professional medical guidance.

The price of genuine imfinzi (Imfinzi)

Understanding the genuine price and related information of imfinzi can help patients plan their treatment costs reasonably.

Marketing status and price analysis

Durvalumab was launched in China in December 2019. The original drug is produced by Abraxis BioScience in the United States, and the price of a single box is approximately US$664. Since it is not covered by medical insurance, patients need to pay for it at their own expense. Some generic versions of durvalumab are already on the market, but the price is not yet clear.

Reasons for not being covered by medical insurance

Durvalumab has not been included in the medical insurance catalog yet, which may be related to factors such as high drug pricing and the progress of medical insurance negotiations. Currently, patients can obtain drugs through medical institutions or formal online platforms. When purchasing, they need to check the drug approval number and production batch number to ensure reliable sources.

After purchasing durvalumab, you can initially judge the authenticity by checking the packaging integrity, anti-counterfeiting labels and drug properties (such as clear to opalescent liquid).

How to store imfinzi after purchasing it

Correct storage method can ensure the efficacy of the drug and avoid the risk of deterioration.

Original drug storage requirements

Unopened durvalumab needs to be kept refrigerated in a refrigerator at 2°C to 8°C and placed in the original carton to avoid light. Avoid freezing or shaking vigorously as this may cause the medication to become ineffective. Before opening, check whether the medicinal solution is clear. If turbidity or particulate matter appears, stop using it.

Storage and use after preparation

If durvalumab is not used immediately after dilution, it can be stored at 2°C to 8°C for up to 28 days and at room temperature (≤25°C) for no more than 8 hours. Before infusion, it is necessary to observe whether the color of the medicinal solution is colorless to light yellow, and the infusion time should be controlled within 60 minutes. When combined with other drugs, the infusion sequence requirements must be followed.

It is recommended to mark the opening date on the drug packaging and check the storage temperature regularly. If you find that the storage conditions are not up to standard, you should consult your pharmacist or doctor whether you can continue to use it.

Daily care for patients with lung cancer

Scientific care can improve patients’ quality of life and assist in treatment effects.

Diet and Nutrition Management

Lung cancer patients should maintain a high-protein, high-vitamin diet, such as eggs, fish, fresh fruits and vegetables, etc., and avoid spicy and irritating foods. Appetite may decrease during treatment, and small meals may be taken. If severe malnutrition occurs, nutritional supplements need to be used under the guidance of a doctor.

Exercise and psychological support

Moderate exercise such as walking and yoga can help improve physical fitness, but overexertion must be avoided. Patients can relieve their anxiety through family companionship, psychological counseling, or communication with patients. It is recommended to regularly participate in health education activities organized by doctors to learn about disease management.

Environment and living habits

Maintain air circulation in the living environment and avoid contact with second-hand smoke, dust and other irritating substances. Quit smoking and reduce alcohol intake, and maintain a regular schedule to strengthen immunity. You must wear a mask when going out during treatment to reduce the risk of infection.

If you have persistent cough, difficulty breathing or unexplained fever, you should contact your doctor promptly. After taking medication, blood routine, liver and kidney function and lung CT should be reviewed regularly to monitor drug side effects and changes in condition.